Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Net Margin (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Net Margin for 10 consecutive years, with 461.0% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Net Margin changed N/A year-over-year to 461.0%, compared with a TTM value of 1824.2% through Sep 2025, changed N/A, and an annual FY2024 reading of 1998.5%, changed N/A over the prior year.
  • Net Margin was 461.0% for Q4 2024 at Lisata Therapeutics, down from 244680.13% in the prior quarter.
  • Across five years, Net Margin topped out at 461.0% in Q4 2024 and bottomed at 461.0% in Q4 2024.